Dutch.

Consider the particular economics of a dog with an ear infection on a Sunday night. The dog cannot tell you what hurts. The nearest veterinary clinic is booked for two weeks, closed until Monday, or ninety minutes away - and for roughly 38% of Americans, who Dutch's own research says live in a "veterinary desert," some version of all three is true at once. So the pet owner does the thing everyone does: they type the symptoms into a search bar at 11 p.m. and hope.

Dutch is a company built almost entirely around that moment. Founded in 2021 in Oakland, California, it is a direct-to-consumer pet telehealth platform: for a membership that starts around $15 a month, dog and cat owners get unlimited video consultations with licensed veterinarians, personalized treatment plans, and - where state law permits - prescription medication shipped to the door. It treats more than 150 non-emergency conditions, the daily catalog of pet ailments: anxiety, skin and ear allergies, urinary trouble, the itch that won't quit.

The name attached to this is worth pausing on. Dutch was founded by Joe Spector, who previously co-founded Hims & Hers, the human-telehealth company that grew into a multibillion-dollar business by making it easy to get treated for the conditions people were too busy, too far away, or too embarrassed to see a doctor about. Spector's insight the second time around was that the same access problem exists in the roughly 90 million American households with a pet - and that a phone plus a licensed vet could cover a surprising amount of the ground that brick-and-mortar clinics can't.

What makes Dutch more interesting than "video chat with a vet" is what sits underneath it. The company didn't rent its infrastructure; it built its own electronic medical record, its own prescription systems, and its own network of pharmacy and clinic relationships. This is the unglamorous plumbing of healthcare, and it is also, not coincidentally, the moat. Anyone can put a vet on a video call. Fewer companies can legally get a prescription from that call into a pet owner's hands - which is exactly why Dutch's map matters: licensed vets in all 50 states, but prescribing in 34, because each state writes its own telemedicine rules and Dutch has to earn the map one jurisdiction at a time.

The most telling number in the whole operation isn't the funding total or the visit count. It's this: Dutch integrated AI from OpenAI and Google Gemini into its EMR, and the result was that a veterinarian's documentation time dropped from about 20 minutes per visit to roughly five. That is not a chatbot for pet owners. It is a quiet productivity shift that lets a vet see twice as many animals in a day - which, in a category defined by scarcity of licensed professionals, is the whole ballgame. The highest-value AI here isn't the one talking to the customer. It's the one giving the expert their afternoon back.

Since launch, Dutch says it has logged more than 700,000 virtual visits. That is not a pilot; that is a system running at scale, funded by $43 million raised across a seed round (backed, memorably, by Jimmy Fallon and Forerunner Ventures), a $20 million Series A in early 2022, and an $18 million Series B in late 2023. The company projects that roughly 20% of all veterinary visits will be virtual by 2030 - and it is building the rails on the bet that it's right.